Ospolot, as an antiepileptic drug, requires attention to individual differences in efficacy and standardized discontinuation procedures. Its therapeutic effect is related to patient type and medication regimen, and should be gradually reduced and monitored for seizures when discontinued. The following provides specific explanations from two aspects: treatment effectiveness and precautions for discontinuing medication.
1. Treatment effect
(1) Clinical data shows that about 60% -70% of patients with partial seizures can achieve a reduction in seizure frequency of ≥ 50% with monotherapy, while the control rate of generalized tonic clonic seizures is slightly lower by about 50%.
(2) The effective time is 2-4 weeks after the blood drug concentration reaches steady state, and the final effect needs to be evaluated by continuous medication for 3 months. Ineffective individuals should consider switching to other antiepileptic drugs.
(3) The therapeutic effect of children over 6 years old is equivalent to that of adults, but attention should be paid to weight adjustment dosage. The therapeutic effect on Lennox Gastaut syndrome is limited.
2 Precautions for discontinuation of medication
(4) The principle of reducing dosage is that patients who have not experienced symptoms for more than 2 years may consider discontinuing the medication. The dosage should be reduced by 25% every 2-4 weeks, and the total course of treatment should not be less than 6 months. Sudden discontinuation of medication may trigger status epilepticus.
(5) During the monitoring requirement reduction period, the EEG should be rechecked monthly. If there are premonitory attacks or abnormal EEG, the reduction should be suspended. Continue to observe for 6 months after discontinuing the medication.
(6) It is not recommended to discontinue medication for high-risk factors such as a history of status epilepticus, multiple seizure types, or abnormal brain structure. The recurrence rate after discontinuation of medication can reach 40%.
3 Special precautions
(7) When traveling and transporting in environments above 30 ℃, insulation bags must be used, and the continuous exposure time should not exceed 48 hours.
(8) Deterioration judgment
Do not take pills when they change color, swell, or have an odor.
Disclaimer:《What is the therapeutic effect of Desitin Arzneimitel GmbH version of Ospolot in Germany? Is there anything to pay attention to when patients stop taking medication?》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:Sultiame、Ospolot、舒噻嗪
Reference Price:$1310.00
Prescribing Information: Ospolot(舒噻嗪)是一种磺胺类衍生物抗癫痫药物,其结构与其它抗惊厥药物无相似性。 一、药品名称 1、通用名:舒噻嗪(Sultiame) 2、商品名:Ospolot 二、适应症 用于治疗睡眠中持续性棘慢波综合征(POCS),仅限于可用的、适当的其他治疗方法...